Symbol="MDGL"
AssetType="Common Stock"
Name="Madrigal Pharmaceuticals Inc"
Description="Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic and liver diseases. The company is headquartered in West Conshohocken, Pennsylvania."
CIK="1157601"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3980279000"
EBITDA="-313836000"
PERatio="None"
PEGRatio="0"
BookValue="8.21"
DividendPerShare="0"
DividendYield="0"
EPS="-15.54"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.708"
ReturnOnEquityTTM="-2.127"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-15.54"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="331.17"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="93.6"
EVToRevenue="-"
EVToEBITDA="-3.293"
Beta="-0.705"
num_52WeekHigh="322.67"
num_52WeekLow="57.21"
num_50DayMovingAverage="271.0"
num_200DayMovingAverage="205.8"
SharesOutstanding="18289200"
DividendDate="2016-07-25"
ExDividendDate="None"
symbol="MDGL"
open="220.28"
high="222.80"
low="216.16"
price="219.13"
volume="177917.00"
latest_trading_day="2023-07-07"
previous_close="220.53"
change="-1.40"
change_percent="-0.6348%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="32"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="68"
Volume_recent_avg="402683"
Change_recent_avg="-0.44"
Delta_recent_avg="13.62"
Variance_recent_avg="6.81"
Change_ratio_recent_avg="-0.25"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="68"
Aroon_momentum_negative="32"
image_negative_thumbnail_id_1="124"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0052.jpeg"
image_negative_thumbnail_id_2="1102"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0135.jpeg"
image_neutral_thumbnail_id_1="533"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_neutral_thumbnail_id_2="557"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0042.jpeg"
image_positive_thumbnail_id_1="696"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0012.jpeg"
image_positive_thumbnail_id_2="955"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0117.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1201"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
